NO168943C - Fremgangsmaate ved fremstilling av gammaglobulin som er egnet for intravenoes administrering - Google Patents

Fremgangsmaate ved fremstilling av gammaglobulin som er egnet for intravenoes administrering

Info

Publication number
NO168943C
NO168943C NO86860848A NO860848A NO168943C NO 168943 C NO168943 C NO 168943C NO 86860848 A NO86860848 A NO 86860848A NO 860848 A NO860848 A NO 860848A NO 168943 C NO168943 C NO 168943C
Authority
NO
Norway
Prior art keywords
concn
intravenoes
gammaglobulin
administration
procedure
Prior art date
Application number
NO86860848A
Other languages
English (en)
Norwegian (no)
Other versions
NO860848L (no
NO168943B (no
Inventor
Juergen-Diet Friedrich-Fiechtl
Bernhard Kerner
Juergen Holzapfel
Martin Puschmann
Tokusuke Kimura
Fumio Kurosu
Original Assignee
Armour Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26091956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO168943(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Armour Pharma Gmbh filed Critical Armour Pharma Gmbh
Publication of NO860848L publication Critical patent/NO860848L/no
Publication of NO168943B publication Critical patent/NO168943B/no
Publication of NO168943C publication Critical patent/NO168943C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO86860848A 1984-07-07 1986-03-06 Fremgangsmaate ved fremstilling av gammaglobulin som er egnet for intravenoes administrering NO168943C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP84107985A EP0168506B2 (en) 1984-07-07 1984-07-07 Process for preparing gamma globulin suitable for intravenous administration
PCT/EP1985/000320 WO1986000530A1 (en) 1984-07-07 1985-07-03 Process for preparing gamma globulin suitable for intravenous administration
JP7263622A JPH08319241A (ja) 1984-07-07 1995-09-19 静脈注射用ガンマグロブリン組成物

Publications (3)

Publication Number Publication Date
NO860848L NO860848L (no) 1986-03-06
NO168943B NO168943B (no) 1992-01-13
NO168943C true NO168943C (no) 1992-04-22

Family

ID=26091956

Family Applications (1)

Application Number Title Priority Date Filing Date
NO86860848A NO168943C (no) 1984-07-07 1986-03-06 Fremgangsmaate ved fremstilling av gammaglobulin som er egnet for intravenoes administrering

Country Status (8)

Country Link
EP (1) EP0168506B2 (da)
JP (2) JPH0816065B2 (da)
AT (1) ATE59144T1 (da)
DE (1) DE3483784D1 (da)
DK (1) DK164023C (da)
FI (1) FI84136C (da)
NO (1) NO168943C (da)
WO (1) WO1986000530A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
EP3088412B1 (en) 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Protein purification method
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
US9403899B2 (en) 2011-08-26 2016-08-02 Baxalta Incorporated Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
JPS57203017A (en) * 1981-06-09 1982-12-13 Fujirebio Inc Purifying method of immunoglobulin
EP0078331B1 (en) * 1981-10-29 1986-01-29 Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection

Also Published As

Publication number Publication date
JPH08319241A (ja) 1996-12-03
ATE59144T1 (de) 1991-01-15
FI860350L (fi) 1986-01-24
DK164023B (da) 1992-05-04
FI84136B (fi) 1991-07-15
EP0168506B2 (en) 1998-01-07
DK97286D0 (da) 1986-03-04
NO860848L (no) 1986-03-06
FI860350A0 (fi) 1986-01-24
DK97286A (da) 1986-03-04
DK164023C (da) 1992-09-28
DE3483784D1 (de) 1991-01-31
EP0168506B1 (en) 1990-12-19
WO1986000530A1 (en) 1986-01-30
JPS61500972A (ja) 1986-05-15
EP0168506A1 (en) 1986-01-22
NO168943B (no) 1992-01-13
JPH0816065B2 (ja) 1996-02-21
FI84136C (fi) 1991-10-25

Similar Documents

Publication Publication Date Title
SE7903817L (sv) Moranolinderivat
Pesanti et al. Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage.
TR199700574T1 (xx) Molek�ler �aperon �retiminin haz�rlanmas� i�in yararl� hidroksilamin t�revleri ve bu t�revlerin haz�rlanmas�.
Levvy et al. Purification of β-glucuronidase from the preputial gland of the female rat
ATE84967T1 (de) Verwendung von pentoxifyllin zur behandlung entzuendlicher erkrankungen.
Furuta et al. Anorexia nervosa with severe liver dysfunction and subsequent critical complications
Derechin The assay of human plasminogen with casein as substrate
Li et al. Effect of oxygen tension on the anti-oxidant enzyme activities of tetralogy of Fallot ventricular myocytes
Boyland et al. Enzyme activity in relation to cancer: inhibition of urinary β-glucuronidase of patients with cancer of the bladder by oral administration of 1: 4-saccharolactone and related compounds
FI844557L (fi) Koncentrat av antihemofilfaktorn viii och foerfarande foer framstaellning av detsamma.
KR880013572A (ko) 인슐린 및 인슐린 유도체의 혼합결정체, 이의 제조방법, 이를 함유하는 약제 및 이의 용도
NO168943C (no) Fremgangsmaate ved fremstilling av gammaglobulin som er egnet for intravenoes administrering
FI854179L (fi) Antibakterieblandning och framstaellningsfoerfarande foer dess aktiva aemnen.
GB1495289A (en) Pharmaceutically active proteinaceous compounds
DeMartino et al. ATP-stimulated degradation of endogenous proteins in cell free extracts of BHK 21/C13 fibroblasts A key role for the proteinase, macropain, in the ubiquitin-dependent degradation of short-lived proteins
Schumacher et al. Intravascular degranulation of neutrophils: an important factor in inflammation?
Welsh et al. Heat-shock treatment of mouse pancreatic islets results in a partial loss of islet cells but no remaining functional impairment among the surviving β cells
Moav et al. Activation of the fibrinolytic system of the guinea pig following inoculation of Echis colorata venom
Lowenthal et al. The inhibition of hyaluronidase by sodium salicylate and its possible metabolites
Frankl et al. Enzyme activity in the serum and common duct bile of dogs
Foá-Tomasi et al. Enhanced inhibition of RNA synthesis by amanitins in in vitro cultured cells
US3657425A (en) Beef insulin preparations
Castermans et al. Transplantation immunity: separation of antigenic components from isolated nuclei
Frank Aldose reductase activity and basement membrane thickening
Nellas et al. Pancreatic collagenase therapy for severe, progressive systemic sclerosis: Effect on skin and on hydroxyproline content in urine